You just read:

TaiwanJ Pharmaceuticals Announces Positive Results from Phase 2 Orphan Drug Designation Study of JKB-122 on Autoimmune Hepatitis (AIH)

News provided by

TaiwanJ Pharmaceuticals Co., Ltd.

Jan 21, 2019, 21:45 ET